An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K.

Who's giving a half-billion-dollar jolt to Power Station project? © 2025 American City Business Journals. All rights reserved ...

A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility Tuesday in Smithfield.

One company says it gets 200 resumes for every job it posts. The Business of Pride Business of Pride Annual Celebration and Awards Ceremony! Another big biotech pledges billions for U.S ...

The incarcerated former Silicon Valley star is advising her partner on a new health tech startup. Holmes was convicted of ...

Holmes told People magazine in February that she intends to resume her career in biotech when she is released from prison and that she has been writing patents for new inventions while behind bars.

Vaxart, Inc. (NASDAQ:VXRT), a biotechnology company specializing ... follow-up activities for a 400-person cohort, can now resume incurring costs and preparing for a 10,000 participant trial.

the government has notified Vaxart that the study can resume, according to April 24 documents filed with the Securities and Exchange Commission (SEC). The HHS has not responded to Fierce Biotech's ...

With the hold now lifted, Atara is allowed to resume its phase 3 Allele study of Ebvallo for patients with Epstein-Barr virus-associated post-transplant lymphoproliferative disease as well as a ...